These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7777474)

  • 1. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification.
    Jakić-Razumović J; Petrovecki M; Dominis M
    Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma.
    Iyer VK; Raina V; Dawar R
    Indian J Cancer; 2000 Dec; 37(4):140-7. PubMed ID: 12018565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The nucleolar organizer region in malignant non-Hodgkin's lymphoma].
    Jakić-Razumović J; Labar B; Cör A; Radman I
    Lijec Vjesn; 1992; 114(1-4):18-21. PubMed ID: 1343017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative study of AgNOR in differential diagnosis between non-Hodgkin's lymphoma and reactive hyperplasia.
    Gan X
    Chin Med J (Engl); 1995 Feb; 108(2):132-7. PubMed ID: 7774388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.
    Crocker J; Macartney JC; Smith PJ
    J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions in lymphomas: a quantitative study.
    Yekeler H; Ozercan MR; Yumbul AZ; Ağan M; Ozercan IH
    Pathologica; 1993; 85(1097):353-60. PubMed ID: 8233651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
    Arora B; Kumar S; Jain R
    J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma.
    Shimizu K; Izumi R; Ii T; Muraoka K; Inoue T; Fukushima W; Sakamoto K; Tani T; Hashimoto T; Yagi M
    Hepatology; 1995 Feb; 21(2):393-7. PubMed ID: 7843711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric analysis of AgNORs in the lymph node lesions.
    Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
    Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas.
    Crocker J; Egan MJ
    J Pathol; 1988 Nov; 156(3):233-9. PubMed ID: 3060577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K
    Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polymerase alpha-reacting cells in non-Hodgkin's lymphomas.
    Okabe Y; Nakamura S; Okumura H; Matano S; Kobayashi K; Ohtake S; Yoshida T; Matsuda T; Mizukami Y; Nonomura A
    Anticancer Res; 1991; 11(6):2031-5. PubMed ID: 1723261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
    Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
    Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
    Nizze H; Bühring U
    Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma].
    Glińska H; Papla B; Siuda M; Zulichowska J
    Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.
    Jakić-Razumović J; Tentor D; Petrovecki M; Radman I
    J Clin Pathol; 1993 Oct; 46(10):943-7. PubMed ID: 8227414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
    Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
    Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.